On January 10, 2022, Paul Trower notified Incyte Corporation of his intention to retire as Division Vice President, Finance and Principal Accounting Officer of the Company effective March 11, 2022. Effective March 11, 2022, the board of directors of the Company appointed Thomas Tray as the Company's Vice President, Finance and Chief Accounting Officer (Principal Accounting Officer). Mr. Tray joined the Company in June 2005 as Manager, External Reporting, and has held roles of increasing responsibility, most recently as Vice President and Controller.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.68 USD | +0.98% | -0.46% | -17.69% |
Apr. 24 | Oppenheimer Adjusts Incyte Price Target to $84 From $92, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.69% | 11.49B | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.27% | 29.48B | |
+57.86% | 25.43B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B | |
+2.29% | 7.67B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Incyte Corporation Announces Executive Changes, Effective March 11, 2022